drugset / Trial / NCT01849042
Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the pharmacological efficacy on language capability and compliance with combination of new Ebixa oral pump and donepezil compared to donepezil only in patients with probable Alzheimer's disease. Primary objective is to evaluate the efficacy of memantine on language capability in moderate to severe Alzheimer's disease patients who are taking stable donepezil treatment.Secondary objectives are to evaluate the efficacy of maintain on cognitive function and disease progression with K-MMSE, NPI, ROSA, and SIB-short form in probable AD.
Timeline
- Start
- 2013-01
- Primary completion
- 2014-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Memantine | Unknown | 20 mg | Oral |
| Background | Donepezil | Small molecule | 5 mg | — |
| Background | Donepezil | Small molecule | 10 mg | — |